III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003332.
The VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is an adult-onset systemic autoinflammatory condition that is caused by an acquired deficiency of the UBA1 gene in hematopoietic progenitor cells. The clinical spectrum of the VEXAS syndrome currently comprises a broad range of phenotypes such as vasculitis, relapsing polychondritis and Sweet's syndrome. In the past, VEXAS patients have left clinicians puzzled and the true nature of this disease has not been captured until late 2020. This viewpoint describes the relevant clinical features of the VEXAS syndrome and reviews different approaches to establish the diagnosis. Finally, future directions within the field of systemic inflammatory diseases caused by somatic mutations are being discussed.
VEXAS 综合征(空泡、E1 酶、X 连锁、自身炎症、体细胞)是一种后天获得性造血祖细胞 UBA1 基因突变导致的成人发病的系统性自身炎症性疾病。目前,VEXAS 综合征的临床表现谱广泛,包括血管炎、复发性多软骨炎和 Sweet 综合征等多种表型。过去,VEXAS 患者让临床医生感到困惑,直到 2020 年末,这种疾病的真正性质才被揭示。本观点描述了 VEXAS 综合征的相关临床特征,并回顾了不同的诊断方法。最后,还讨论了体细胞突变引起的系统性炎症性疾病领域的未来发展方向。